HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis

被引:20
作者
Fraile, A
Martin, J
López-Nevot, MA
Mataran, L
Nieto, A
机构
[1] Inst Parasitol & Biomed Lopez Neyra, CSIC, Granada 18001, Spain
[2] Hosp Virgen Nieves, Granada, Spain
来源
TISSUE ANTIGENS | 1998年 / 52卷 / 05期
关键词
ankylosing spondylitis; HLA-B*27 subtypes; PCR-RFLP;
D O I
10.1111/j.1399-0039.1998.tb03078.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We describe the use of restriction analysis on PCR-amplified DNA for detecting all B*27 subtypes except B*2710 and B*2711 (i.e. from B*2701 to B*2709). After detecting B*27 by Sty,I,double digestions consisting of Sty I plus another informative enzyme led to subtype assignment We used mismatched primers to create restriction sites when necessary. The method avoids group-specific amplifications and other laborious optimization procedures. It was successfully tested on a panel of well characterized cell lines covering different B*27 subtypes. Then, Rie studied a group of 57 ankylosing spandylitis patients and 746 controls from the south of Spain. B*27 showed a very strong association with the disease (OR=211.27, P=10(-7)). B*2702 and B*2705 distribution in controls (20% and 77.1%, respectively) differed from previously reported data in the Spanish population. We unexpectedly found the B*2707 allele in our population (one control).
引用
收藏
页码:492 / 496
页数:5
相关论文
共 20 条
[1]   Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing [J].
Blasczyk, R ;
Weber, M ;
vanLessen, A ;
Schwella, N ;
Huhn, D ;
Salama, A .
HUMAN IMMUNOLOGY, 1996, 45 (02) :117-123
[2]   DISTRIBUTION OF HLA-B27 SUBTYPES IN PATIENTS WITH ANKYLOSING-SPONDYLITIS - THE DISEASE IS ASSOCIATED WITH A COMMON DETERMINANT OF THE VARIOUS B27 MOLECULES [J].
BREURVRIESENDORP, BS ;
DEKKERSAEYS, AJ ;
IVANYI, P .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (05) :353-356
[3]  
BREWERTON DA, 1973, LANCET, V1, P904
[4]   RELEVANCE OF RESIDUE-116 OF HLA-B27 IN DETERMINING SUSCEPTIBILITY TO ANKYLOSING-SPONDYLITIS [J].
DAMATO, M ;
FIORILLO, MT ;
CARCASSI, C ;
MATHIEU, A ;
ZUCCARELLI, A ;
BITTI, PP ;
TOSI, R ;
SORRENTINO, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3199-3201
[5]  
DOMINGUEZ O, 1992, IMMUNOGENETICS, V36, P277
[6]  
DYER P, 1994, HLA DIS, P93
[7]   Typing for TAP alleles using PCR-RFLP with amplification-created restriction sites [J].
Fraile, A ;
Vinasco, J ;
Nieto, A ;
Pareja, E ;
Martin, J .
TISSUE ANTIGENS, 1996, 47 (04) :346-352
[8]   MOLECULAR ANALYSIS OF HLA-B27 HAPLOTYPES IN CAUCASOIDS - FREQUENCIES OF B27-CW IN JEWISH AND SPANISH POPULATIONS [J].
GONZALEZROCES, S ;
BRAUTBAR, C ;
PENA, M ;
DOMINGUEZ, O ;
COTO, E ;
ALVAREZ, V ;
SEGAL, R ;
LOPEZLARREA, C .
HUMAN IMMUNOLOGY, 1994, 41 (02) :127-134
[9]   HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis [J].
GonzalezRoces, S ;
Alvarez, MV ;
Gonzalez, S ;
Dieye, A ;
Makni, H ;
Woodfield, DG ;
Housan, L ;
Konenkov, V ;
Abbadi, MC ;
Grunnet, N ;
Coto, E ;
LopezLarrea, C .
TISSUE ANTIGENS, 1997, 49 (02) :116-123
[10]   MODIFICATION OF ENZYMATICALLY AMPLIFIED DNA FOR THE DETECTION OF POINT MUTATIONS [J].
HALIASSOS, A ;
CHOMEL, JC ;
TESSON, L ;
BAUDIS, M ;
KRUH, J ;
KAPLAN, JC ;
KITZIS, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (09) :3606-3606